Announcement
31 Jul 2026
In July 2026, the U.S. Administration reduced the Section 232 tariff rate on patented pharmaceutical imports from the United Kingdom from 10% to zero.
Source
Sign in to access
Number of interventions
1
0 certainly harmful
0 likely harmful
1 liberalising
List of interventions
Implementation date
31 Jul 2026
Revocation date:
No revocation date
Announced: 31 Jul 2026
Import tariff In force
Recent update from 03 Aug 2026:
On 31 July 2026, the Bureau of Industry and Security of the U.S. Department of Commerce issued a notice reducing the Section 232 tariff rate on patented pharmaceuticals and associated pharmaceutica...
Sign in to see more
Related State Acts
Announced: 01 Dec 2025
United States of America: U.S. Administration’s commitments under an agreement on pharmaceutical pricing with the United Kingdom
Announced: 01 Dec 2025
United Kingdom: UK Government’s commitments under an agreement on pharmaceuticals with the United States
Clarification: 30 Jul 2026
United States of America: U.S. Administration imposes Section 232 tariffs on pharmaceutical imports
Threads
See all
This state act is not part of any Thread yet.